Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,677	10,576	25,891	16,074	8,451	2,820
Market Cap Growth	95.22%	-59.15%	61.07%	90.20%	199.72%	-18.91%
Enterprise Value	14,112	8,085	23,747	15,869	8,249	2,326
Last Close Price	106.00	73.58	179.00	118.61	65.86	23.12
PE Ratio	23.39	22.37	35.62	-	-	-
PS Ratio	10.31	12.73	23.40	81.32	289.08	97.71
PB Ratio	3.71	3.39	9.39	22.29	18.25	5.23
P/TBV Ratio	4.49	4.89	9.52	23.46	19.80	5.59
P/FCF Ratio	94.95	21.59	38.79	-	-	-
P/OCF Ratio	85.85	21.25	38.74	-	-	-
EV/Sales Ratio	8.72	9.73	21.47	80.28	282.15	80.61
EV/EBITDA Ratio	14.21	19.20	34.00	-	-	-
EV/EBIT Ratio	16.27	19.34	34.25	-	-	-
EV/FCF Ratio	80.34	16.51	35.58	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.03	0.03
Debt / EBITDA Ratio	0.05	0.09	0.02	-	-	-
Debt / FCF Ratio	0.28	0.08	0.02	-	-	-
Asset Turnover	-	0.26	0.58	0.31	0.05	0.04
Quick Ratio	32.25	8.49	12.89	11.63	10.05	9.05
Current Ratio	32.44	8.72	12.96	13.07	10.57	10.79
Return on Equity (ROE)	-	16.10%	41.81%	-6.76%	-49.43%	-41.47%
Return on Assets (ROA)	-	8.07%	22.64%	-8.54%	-29.36%	-27.20%
Return on Capital (ROIC)	-	8.82%	24.62%	-8.99%	-30.89%	-28.46%
Return on Capital Employed (ROCE)	18.80%	13.10%	24.50%	-11.80%	-54.20%	-58.30%
Earnings Yield	4.10%	4.47%	2.81%	-0.25%	-2.93%	-10.00%
FCF Yield	1.05%	4.63%	2.58%	-1.32%	-2.19%	-11.20%
Dividend Yield	1.42%	2.04%	0.56%	-	-	-
Payout Ratio	33.25%	29.84%	-	-	-	-
Buyback Yield / Dilution	-6.72%	-4.73%	-7.29%	-6.65%	-1.87%	-5.35%
Total Shareholder Return	-5.34%	-2.69%	-6.73%	-6.65%	-1.87%	-5.35%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.